A 12‐week treatment of children aged 1–12 years with moderate AD using tyndallizate Lactobacillus rhamnosus IDCC 3201 (RHT3201) resulted in a significant reduction in AD scores, as well as in eosinophil cationic protein and IL‐31 levels.387. This evidence concerns the gene IL31 and Alzheimer disease.